Home / Posts Tagged "IRDAI"

MeshApp, a groundbreaking solution, redefining efficiency in the healthcare sector, specifically for doctors and medical representatives (MRs), is thrilled to announce that in a significant step towards bridging gaps between the medical and pharmaceutical communities, MeshApp has launched a powerful digital platform that reimagines how doctors and

READ MORE

Combines two proven blockbuster monoclonal antibodies: Perjeta® (pertuzumab) and Herceptin® (trastuzumab) in single vial for subcutaneous administration Is also the world’s first subcutaneous therapy for breast cancer that offers faster, more comfortable administration of Perjeta and Herceptin under the skin in just minutes, compared

READ MORE